HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)

CNY 8.18

(-5.43%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 7.42 Billion 7.05 Billion 6.74 Billion 5.99 Billion 5.54 Billion 4.41 Billion
Total Current Assets 6.92 Billion 6.54 Billion 6.18 Billion 5.53 Billion 5.07 Billion 3.92 Billion
Cash And Short Term Investments 1.31 Billion 1.18 Billion 800.49 Million 416.81 Million 367.2 Million 505.69 Million
Cash and Cash Equivalents 1.31 Billion 1.18 Billion 800.49 Million 416.81 Million 367.2 Million 505.69 Million
Short Term Investments - - - - - -
Net Receivables 4.45 Billion 4.24 Billion 4.23 Billion 3.93 Billion 3.52 Billion 2.53 Billion
Inventory 1.11 Billion 1.07 Billion 1.1 Billion 1.12 Billion 1.14 Billion 852.54 Million
Other Current Assets 38.61 Million 43.97 Million 41.59 Million 60.79 Million 33.33 Million 28.97 Million
Total Non-Current Assets 501.83 Million 512.33 Million 562.5 Million 459.34 Million 474.16 Million 488.93 Million
Net PPE 356.66 Million 367.8 Million 410.83 Million 312.42 Million 330.55 Million 346.13 Million
Good Will And Intangible Assets 26.49 Million 28 Million 29.28 Million 26.59 Million 26.4 Million 27.14 Million
Good Will - - - - - -
Intangible Assets 26.49 Million 28 Million 29.28 Million 26.59 Million 26.4 Million 27.14 Million
Long-Term Investments 39.76 Million 40.53 Million 43.13 Million -257.34 Million 47.48 Million 1.00
Tax Assets 67.69 Million 64.17 Million 67.15 Million 65.23 Million 60.49 Million 54.7 Million
Other Non Current Assets 11.2 Million 11.8 Million 12.08 Million 312.42 Million 9.22 Million 60.95 Million
Other Assets - 1.00 1.00 1.00 - 1.00
Total Liabilities 4.55 Billion 4.59 Billion 4.54 Billion 4 Billion 3.7 Billion 2.83 Billion
Total Current Liabilities 4.52 Billion 4.43 Billion 4.35 Billion 3.86 Billion 3.56 Billion 2.68 Billion
Account Payables 1.6 Billion 2.61 Billion 2.47 Billion 2.67 Billion 2.59 Billion 2.09 Billion
Tax Payables 43.33 Million 51.97 Million 47.88 Million 49.19 Million 45.34 Million 13.83 Million
Short Term Debt 2.3 Billion 1.22 Billion 1.26 Billion 610.69 Million 524 Million 224 Million
Deferred Revenue 15.99 Million 11.45 Million 570.76 Million 538.78 Million 412.07 Million 13.83 Million
Other Current Liabilities 600.76 Million 576.07 Million 39.9 Million 42.07 Million 24.87 Million 357.6 Million
Total Non Current Liabilities 33.59 Million 164.75 Million 191.91 Million 139.92 Million 139.82 Million 145.62 Million
Long-Term Debt 29.4 Million 38.48 Million 59.58 Million 34.45 Million - -
Deferred Revenue Non Current 120.94 Million 125.7 Million 130.77 Million 137.34 Million 139.82 Million 145.62 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -120.8 Million 565.77 Thousand 1.56 Million 2.58 Million - -
Other Liabilities 1.00 - 1.00 - 1.00 -
Total Equity 2.75 Billion 2.46 Billion 2.19 Billion 1.99 Billion 1.84 Billion 1.57 Billion
Stock Holders Equity 2.75 Billion 2.46 Billion 2.2 Billion 1.99 Billion 1.84 Billion 1.57 Billion
Common Stock 579.88 Million 579.88 Million 579.88 Million 579.88 Million 579.88 Million 579.88 Million
Retained Earnings 2.06 Billion 1.77 Billion 1.51 Billion 1.3 Billion 1.18 Billion 934.22 Million
Accumulated other comprehensive income 104.54 Million 104.49 Million 104.29 Million 104.08 Million 85.5 Million 65.83 Million
Common Stock Equity 2.75 Billion 2.46 Billion 2.2 Billion 1.99 Billion 1.84 Billion 1.57 Billion
Capital Lease Obligation 29.4 Million 38.48 Million 59.58 Million 34.45 Million - -
Total Investments 39.76 Million 40.53 Million 43.13 Million -257.34 Million 47.48 Million 1.00
Total Debt 2.33 Billion 1.26 Billion 1.32 Billion 610.69 Million 524 Million 224 Million
Net Debt 1.01 Billion 86.89 Million 527.07 Million 193.87 Million 156.79 Million -281.69 Million

Balance Sheet Charts